Gradišer, M., Matovinović, M., & Vrkljan, M. (2007). Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly. Croatian medical journal, p. 8.
Chicago stil citiranjaGradišer, Marina, Martina Matovinović, and Milan Vrkljan. "Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly." 2007: 8.
MLA stil citiranjaGradišer, Marina, Martina Matovinović, and Milan Vrkljan. "Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly." 2007: 8.